Cargando…

Changes of liver hemodynamic and elastography parameters in patients with colorectal liver metastases receiving preoperative chemotherapy: “a note of caution”

BACKGROUND: New systemic chemotherapy agents have improved prognosis in patients with colorectal liver metastases (CLM), but some of them damage the liver parenchyma and ultimately increase postoperative morbidity and mortality after liver resection. The aims of our study were to determine the degre...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelegrina, Amalia, Martí, Josep, Miquel, Rosa, Ferrer, Joana, Hernández-Gea, Virginia, Diaz, Alba, Nadal, Cristina, García-Valdecasas, Juan Carlos, Fuster, Josep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732417/
https://www.ncbi.nlm.nih.gov/pubmed/29246174
http://dx.doi.org/10.1186/s12957-017-1290-5
_version_ 1783286692475568128
author Pelegrina, Amalia
Martí, Josep
Miquel, Rosa
Ferrer, Joana
Hernández-Gea, Virginia
Diaz, Alba
Nadal, Cristina
García-Valdecasas, Juan Carlos
Fuster, Josep
author_facet Pelegrina, Amalia
Martí, Josep
Miquel, Rosa
Ferrer, Joana
Hernández-Gea, Virginia
Diaz, Alba
Nadal, Cristina
García-Valdecasas, Juan Carlos
Fuster, Josep
author_sort Pelegrina, Amalia
collection PubMed
description BACKGROUND: New systemic chemotherapy agents have improved prognosis in patients with colorectal liver metastases (CLM), but some of them damage the liver parenchyma and ultimately increase postoperative morbidity and mortality after liver resection. The aims of our study were to determine the degree of hemodynamic and pathological liver injury in CLM patients receiving preoperative chemotherapy and to identify an association between these injuries and postoperative complications after liver resection. METHODS: This is a prospective descriptive study of patients with CLM receiving preoperative chemotherapy before curative liver resection from November 2013 to June 2014. All patients had preoperative elastography and hepatic hemodynamic evaluation. We analyzed clinical preoperative data and postoperative outcomes after grouping the patients by chemotherapy type, development of sinusoidal obstructive syndrome (SOS), and development of major complications. RESULTS: Eleven from the 20 patients included in the study received preoperative oxaliplatin-based chemotherapy (OBC). Nine patients had SOS at pathological analysis and five patients developed major complications. Patients receiving preoperative OBC had higher values of hepatic venous pressure gradient (HVPG) and developed more SOS and major complications. Patients developing SOS had higher values of HVPG and developed more major complications. Patients with major complications had higher values of HVPG, and patients with a HVPG of 5 mmHg or greater had more major complications than those under 5 mmHg (20 vs 80%, p = 0.005). CONCLUSIONS: OBC and SOS impair liver hemodynamics in CLM patients. An increase in major complications after liver resection in these patients develops at subclinical HVPG levels.
format Online
Article
Text
id pubmed-5732417
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57324172017-12-21 Changes of liver hemodynamic and elastography parameters in patients with colorectal liver metastases receiving preoperative chemotherapy: “a note of caution” Pelegrina, Amalia Martí, Josep Miquel, Rosa Ferrer, Joana Hernández-Gea, Virginia Diaz, Alba Nadal, Cristina García-Valdecasas, Juan Carlos Fuster, Josep World J Surg Oncol Research BACKGROUND: New systemic chemotherapy agents have improved prognosis in patients with colorectal liver metastases (CLM), but some of them damage the liver parenchyma and ultimately increase postoperative morbidity and mortality after liver resection. The aims of our study were to determine the degree of hemodynamic and pathological liver injury in CLM patients receiving preoperative chemotherapy and to identify an association between these injuries and postoperative complications after liver resection. METHODS: This is a prospective descriptive study of patients with CLM receiving preoperative chemotherapy before curative liver resection from November 2013 to June 2014. All patients had preoperative elastography and hepatic hemodynamic evaluation. We analyzed clinical preoperative data and postoperative outcomes after grouping the patients by chemotherapy type, development of sinusoidal obstructive syndrome (SOS), and development of major complications. RESULTS: Eleven from the 20 patients included in the study received preoperative oxaliplatin-based chemotherapy (OBC). Nine patients had SOS at pathological analysis and five patients developed major complications. Patients receiving preoperative OBC had higher values of hepatic venous pressure gradient (HVPG) and developed more SOS and major complications. Patients developing SOS had higher values of HVPG and developed more major complications. Patients with major complications had higher values of HVPG, and patients with a HVPG of 5 mmHg or greater had more major complications than those under 5 mmHg (20 vs 80%, p = 0.005). CONCLUSIONS: OBC and SOS impair liver hemodynamics in CLM patients. An increase in major complications after liver resection in these patients develops at subclinical HVPG levels. BioMed Central 2017-12-16 /pmc/articles/PMC5732417/ /pubmed/29246174 http://dx.doi.org/10.1186/s12957-017-1290-5 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Pelegrina, Amalia
Martí, Josep
Miquel, Rosa
Ferrer, Joana
Hernández-Gea, Virginia
Diaz, Alba
Nadal, Cristina
García-Valdecasas, Juan Carlos
Fuster, Josep
Changes of liver hemodynamic and elastography parameters in patients with colorectal liver metastases receiving preoperative chemotherapy: “a note of caution”
title Changes of liver hemodynamic and elastography parameters in patients with colorectal liver metastases receiving preoperative chemotherapy: “a note of caution”
title_full Changes of liver hemodynamic and elastography parameters in patients with colorectal liver metastases receiving preoperative chemotherapy: “a note of caution”
title_fullStr Changes of liver hemodynamic and elastography parameters in patients with colorectal liver metastases receiving preoperative chemotherapy: “a note of caution”
title_full_unstemmed Changes of liver hemodynamic and elastography parameters in patients with colorectal liver metastases receiving preoperative chemotherapy: “a note of caution”
title_short Changes of liver hemodynamic and elastography parameters in patients with colorectal liver metastases receiving preoperative chemotherapy: “a note of caution”
title_sort changes of liver hemodynamic and elastography parameters in patients with colorectal liver metastases receiving preoperative chemotherapy: “a note of caution”
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732417/
https://www.ncbi.nlm.nih.gov/pubmed/29246174
http://dx.doi.org/10.1186/s12957-017-1290-5
work_keys_str_mv AT pelegrinaamalia changesofliverhemodynamicandelastographyparametersinpatientswithcolorectallivermetastasesreceivingpreoperativechemotherapyanoteofcaution
AT martijosep changesofliverhemodynamicandelastographyparametersinpatientswithcolorectallivermetastasesreceivingpreoperativechemotherapyanoteofcaution
AT miquelrosa changesofliverhemodynamicandelastographyparametersinpatientswithcolorectallivermetastasesreceivingpreoperativechemotherapyanoteofcaution
AT ferrerjoana changesofliverhemodynamicandelastographyparametersinpatientswithcolorectallivermetastasesreceivingpreoperativechemotherapyanoteofcaution
AT hernandezgeavirginia changesofliverhemodynamicandelastographyparametersinpatientswithcolorectallivermetastasesreceivingpreoperativechemotherapyanoteofcaution
AT diazalba changesofliverhemodynamicandelastographyparametersinpatientswithcolorectallivermetastasesreceivingpreoperativechemotherapyanoteofcaution
AT nadalcristina changesofliverhemodynamicandelastographyparametersinpatientswithcolorectallivermetastasesreceivingpreoperativechemotherapyanoteofcaution
AT garciavaldecasasjuancarlos changesofliverhemodynamicandelastographyparametersinpatientswithcolorectallivermetastasesreceivingpreoperativechemotherapyanoteofcaution
AT fusterjosep changesofliverhemodynamicandelastographyparametersinpatientswithcolorectallivermetastasesreceivingpreoperativechemotherapyanoteofcaution